Integer Holdings Corporation (NYSE:ITGR), announced today that it plans to release financial and operational results for second quarter 2019, at 8 a.m. Eastern Time (ET) on Thursday, August 1, 2019. Following...
Nevro (NVRO) is gaining traction from a fortified international footprint and solid prospects in the SCS market. However, severe rivalry is a lingering woe.
Top-line growth and better performance at Medical and Non-Medical segments benefit Integer Holdings' (ITGR) Q1 results. However, contraction in gross margin remains a dampener.
Integer (ITGR) delivered earnings and revenue surprises of 25.00% and 3.48%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
PLANO, Texas (AP) _ Integer Holdings Corp. (ITGR) on Thursday reported first-quarter earnings of $21.7 million.
~ Strong Growth in Sales and Profit ~
Better-than-expected performance at C&V and Cardiac & Neuromodulation product lines and higher revenues might aid Integer Holdings (ITGR) in Q1. But decline in non-medical sales might be a dampener.
Investors in Integer Holdings Corp saw new options become available today, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ITGR options chain...
Integer (ITGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Buy Stocks for April 22nd
Integer (ITGR) closed at $77.10 in the latest trading session, marking a +0.19% move from the prior day.
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Advanced Micro Devices,...
Integer Holdings Corporation (NYSE:ITGR), announced today that it plans to release financial and operational results for first quarter 2019, at 8 a.m. Eastern Time (ET) on Thursday, May 2, 2019. Following...
Integer (ITGR) strengthens its balance sheet by reducing its leverage ratio from 5.6X at the end of 2017 to 3.5X at 2018 end.
AngioDynamics' (ANGO) OARtrac is the first of its kind radiation dose monitoring platform.
Integer Holdings Corporation ("Integer") (NYSE:ITGR) announced it has received a positive outlook and a reaffirmed B+ long-term issuer credit rating from Standard & Poor's ("S&P"). The positive outlook,...
With the FDA nod, Zimmer Biomet (ZBH) attains the status of being the first company to boast the 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform globally.
Having established a strong foothold in the U.S. market, Genomic Health (GHDX) is now making considerable expansion in the international arena.
Abbott's (ABT) Alinity m diagnostics system and assays will provide increased flexibility and time efficiency while catering to the rising demand for infectious disease testing.
Integer (ITGR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.